Skip to main content

Sponsored By

Lilly

Early Breast Cancer Part 3: Adverse Event Management - Patient Case #1

This “Case-Based Exchange” concludes our 3-part series, featuring discussions on 2 early breast cancer patient cases. Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, share their perspectives on practical, patient-focused strategies for optimal management of abemaciclib-related side effects.

Joyce O’Shaughnessy, MD
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Sarah Cannon Research Institute
Dallas, TX

Related Items

Early Breast Cancer Part 3: Adverse Event Management - Patient Case #2
Early Breast Cancer Part 3: Adverse Event Management - Patient Case #2
Case-Based Exchange: Early Breast Cancer
This “Case-Based Exchange” concludes our 3-part series, featuring discussions on 2 early breast cancer patient cases. Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, share their perspectives on practical, patient-focused strategies for optimal management of abemaciclib-related side effects.
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #1
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #1
Case-Based Exchange: Early Breast Cancer
In this second segment of our 3-part “Case-Based Exchange” series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, discuss 2 patient cases with early breast cancer, outlining methods for fostering active engagement and collaborative conversations with patients and caregivers about the incorporation of abemaciclib into treatment plans.
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #2
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #2
Case-Based Exchange: Early Breast Cancer
In this second segment of our 3-part “Case-Based Exchange” series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, discuss 2 patient cases with early breast cancer, outlining methods for fostering active engagement and collaborative conversations with patients and caregivers about the incorporation of abemaciclib into treatment plans.